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Mitochondria are mainly known as the ‘power house’ of 
eukaryotic  cells  because  they  are  able  to  catalyze  the 
production  of  ATP  through  oxidative  phosphorylation. 
However,  these  organelles  are  not  restricted  to  this 
unique  function  but  fulfill  a  number  of  other  tasks, 
including regulation of calcium homeostasis and amino 
acid metabolism or the citric acid and the urea cycles, 
and as such participate actively in life and death of cells. 
Mitochondria contain their own genome that is packaged 
into  nucleoid-like  structures  containing  several  mito-
chon  drial  DNA  (mtDNA)  molecules.  In  humans,  each 
mtDNA  molecule  encodes  13  proteins,  2  ribosomal 
RNAs and 22 tRNAs. To function correctly, mitochondria 
need  to  be  dynamic:  they  move,  fragment  and  fuse 
continuously. On one hand, fragmentation or fission is 
necessary to produce new mitochondria from a ‘mother 
mitochondrion’ or to isolate and target damaged parts of 
one mitochondrion for degradation by mitophagy [1]. On 
the  other  hand,  fusion  allows  the  mixing  of  matrix 
contents  of  different  mitochondria,  including  their 
genetic information. Impairment of mitochondrial fusion 
leads to accumulation of mutations in the mitochondrial 
genome  and  finally  to  loss  of  mtDNA  molecules  by  a 
mechanism  that  is  still  unclear  [2].  Consequently,  all 
mtDNA-encoded proteins, which are core subunits of the 
respiratory  chain,  are  downregulated  and  oxidative 
phosphorylation is impaired, leading to cell dysfunctions. 
Thus, loss of mtDNA integrity and stability could be the 
cause  of  several  neurodegenerative  disorders  that  have 
been associated with mitochondrial fusion impairment, 
including  the  inherited  diseases  Charcot-Marie-Tooth 
type IIA and optic nerve atrophy. It is therefore important 
to  unravel  the  principles  of  mitochondrial  fusion  by 
identifying all the components that constitute the core 
fusion  machinery  and  to  understand  better  how  this 
machinery is controlled and integrated into cell signaling 
pathways.  In  addition,  it  would  be  useful  to  identify 
chemical  compounds  that  could  modify  mitochondrial 
dynamics for research or therapeutic use. Until now, one 
of  the  limitations  in  the  research  on  mitochondrial 
dynamics, especially in mammals, has been the lack of a 
precise  and  reliable  assay  to  quantify  mitochondrial 
fusion and fission. An important step towards this goal 
has now been accomplished by Schauss and colleagues, 
who have set up an elegant assay allowing quantification 
of mitochondrial fusion in vitro [3].
Some of the key regulators of mitochondrial fusion 
are known
Mitochondrial fusion requires the coordinated fusion of 
the outer and inner membranes. The whole process relies 
largely on dynamin-like proteins that hydrolyze GTP [4]. 
For fusion, mitochondria have mitofusins (Fzo1 in yeast) 
on  the  surface  of  their  outer  membranes  [5].  These 
molecules allow tethering of two organelles before fusion 
of the outer membrane itself occurs. Lipid mixing of the 
outer membrane could be catalyzed by lipid-modifying 
enzymes, such as mitochondrial phospholipase D (mito-
PLD)  [6].  The  mechanism  of  mitochondrial  inner 
membrane fusion is less clear. It has been demonstrated, 
however, that it largely depends on another dynamin-like 
GTPase, Opa1 (Mgm1 in yeast) [7]. It is not known how 
fusion of inner and outer membranes is coordinated in 
mammals,  but  in  yeast  a  third  protein  of  the  outer 
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Mgm1,  may  fulfill  the  role  of  a  membrane  fusion  co-
ordinator  [8].  Mitochondrial  fission  relies  on  the 
cytosolic dynamin-related protein 1 (Drp1 in mammals, 
Dnm1 in yeast), which uses the protein Fis1 as a receptor 
on the mitochondrial outer membrane [9]. Mitochondrial 
dynamins can be regulated by post-translational modifi-
ca  tions,  including  phosphorylation,  sumoylation  and 
ubiquiti  nation [9,10], which impact on their function and 
consequently on mitochondrial shape and dynamics.
Our  knowledge  of  how  mitochondria  fuse  and  frag-
ment  has  significantly  increased  over  the  past  decade, 
mainly thanks to genetic studies performed in Drosophila 
or yeast that allowed identification of key players of these 
processes. However, the picture is incomplete and addi-
tional components of the fusion and fission machineries 
certainly  remain  to  be  identified.  Moreover,  the 
intra  cellular cascades that control these machineries are 
not well characterized yet.
In 2004, Jody Nunnari and colleagues [11] were able to 
induce, for the first time, fusion of isolated mitochondria 
in vitro. Mitochondria of yeast expressing either mito-
chon  drially targeted GFP or dsRed were isolated, mixed, 
centrifuged at 4°C to promote membrane tethering, and 
resuspended at 37°C. Under these conditions, mitochon-
drial fusion could be observed by confocal or electron 
microscopy. This cell-free fusion reaction confirmed the 
requirement of GTP, ATP, an intact membrane potential, 
and Fzo1 and Mgm1 for fusion of the outer and inner 
mitochondrial  membranes,  respectively,  as  shown  in 
previous  cell  fusion  assays  [12].  However,  although 
useful,  this  cell-free  assay  is  not  optimal  to  obtain  a 
reliable  quantification  of  mitochondrial  fusion,  in  part 
because the merge of green and red fluorescent markers 
Figure 1. Identification of new regulators of mitochondrial fusion using a novel quantitative bi-molecular complementation assay. 
(a) Mitochondria from two cell lines expressing either the amino-terminal part of luciferase or its carboxy-terminal part are isolated. (b) Upon 
mixing of both populations, mitochondrial fusion occurs, leading to the reconstitution of the luciferase into a functional protein. The emission 
of light is quantified with a plate reader and is proportional to the amount of mitochondrial fusion. (c) Several parameters of the assay can be 
modified. First, one or both of the cell lines from which mitochondria are isolated can be pre-treated - for example, with chemicals (for example, 
forskolin) or RNA interference (RNAi; for example, PKA). Then, cytosol from different sources can be added to the fusion mixture. At the same time, 
different chemicals can be included in the mixture, which gives rise to the possibility to perform high throughput screens for new modulators of 
mitochondrial dynamics.
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required  to  image  fused  mitochondria  with  a  confocal 
microscope is difficult to combine with automation and 
high-throughput screening.
A new, sensitive, and highly adaptable 
mitochondrial fusion assay
The  novel  assay  described  by  Heidi  McBride  and 
colleagues  [3]  has  overcome  these  limitations  and  has 
been applied to mammalian mitochondria. These authors 
targeted the amino- or carboxy-terminal part of Renilla 
luciferase  to  the  mitochondrial  matrix  of  two  distinct 
human cell lines. In addition, both proteins were fused to 
a  leucine  zipper  to  ensure  their  dimerization.  The 
principle is that upon fusion of mitochondria, the two 
halves  of  luciferase  are  reconstituted  to  a  functional 
protein, able to emit light in the presence of coelentera-
zine  (Figure  1).  The  fusion  protocol,  in  particular  the 
centrifugation step to promote tethering of mitochondria, 
is largely inspired by that described by Meeusen et al. 
[11]. The assay turned out to be very accurate, with an 
impressive  signal-to-noise  ratio,  which  is  essential,  for 
example,  for  high-throughput  screening.  Using  this 
acellular assay, the authors confirmed previous data from 
Meeusen et al. that suggested that, for mitochondria to 
be  fusogenic  in  vitro,  they  need  energy  and  inner 
membrane potential, whereas the presence of cytosol is 
dispensable. However, they observed that in the presence 
of cytosol, mitochondrial fusion was modulated, either 
positively or negatively depending on either the source of 
cytosol  or  its  state  of  activation  at  the  time  of  its 
extraction. For example, addition of cytosol from cells in 
which  the  PKA/cAMP  signaling  pathway  had  been 
activated before extraction led to stimulation of the core 
mitochondrial  fusion  machinery,  as  predicted  by  in 
cellulo data. Thus, the authors were able to reproduce, in 
a  test  tube,  cytosolic  signaling  cascades  leading  to 
quantifiable mitochondrial fusion.
Future directions
These  data  suggest  that  this  assay  could  be  used  as  a 
reliable readout to identify new factors that are part of, or 
control,  the  core  mitochondrial  fusion  machinery. 
Differences in the activities of the cytosols from multiple 
sources suggest a tissue specificity of the factors regula-
ting mitochondrial fusion. These factors could be purified 
by  classical  biochemical  procedures,  their  specific 
activities being measured by Renilla luciferase activities 
in  the  mitochondrial  fusion  assay.  Moreover,  high 
throughput technologies can be envisaged, in particular 
screening of large libraries of chemicals. At the moment, 
only  mitochondria  from  cell  lines  expressing  the  split 
luciferases are available. This may restrict the number of 
assays  performed  and  may  be  a  limitation  for  high 
throughput screening. This limitation could be overcome 
by  expressing  these  luciferase  reporters  in  transgenic 
mice and by isolating mitochondria from different tissues 
of these animals. This would also allow testing whether 
different mitochondria express various forms of the core 
fusion machinery, which may respond differently to the 
signaling cascades. In conclusion, this novel assay should 
be useful to those who more and more are interested in 
quantifying  mitochondrial  fusion  and  should  boost 
research aiming at understanding the mechanisms that 
govern  mitochondrial  dynamics.  Ultimately,  this  could 
lead to better understanding and treatment of mitochon-
drial diseases in humans.
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